This cluster of papers focuses on the occupational exposure of health care workers to antineoplastic drugs, highlighting issues such as surface contamination, biological and environmental monitoring, use of closed-system protective devices, and the assessment of genotoxic effects. The papers also discuss the adherence to safety guidelines and the impact on reproductive health. The research aims to improve practices and reduce risks associated with handling antineoplastic drugs in healthcare settings.